Nobel Biocare finalizes settlement of litigation brought against Blue Sky Bio for patent infringement
Nobel Biocare has announced that the company has reached an agreement with Blue Sky Bio to settle their outstanding patent infringement litigation. Pursuant to this settlement, Nobel Biocare will dismiss its lawsuit and Blue Sky Bio will take a non-exclusive worldwide license to Nobel Biocare’s U.S. Patent No. 5,795,160 and U.S. Patent No. 6,733,291. In return, Nobel Biocare will receive royalty payments from Blue Sky Bio. The amount of those payments was not disclosed.
Further information is available from:
Media:
Mark Macaulay
Sr. Manager, Marketing Communications
North America
Tel: 714-282-4876
Mark.Macaulay@nobelbiocare.com
Disclaimer
This media release contains forward-looking statements based on beliefs of Nobel Biocare's management. When used in this media release, words such as "anticipate", "believe", "estimate", "expect", "intend", "plan" and "project" are intended to identify forward-looking statements. They may involve risks and uncertainties, including technological advances in the medical field, product demand and market acceptance, the effect of economic conditions, the impact of competitive products and pricing, foreign currency exchange rates and other risks. These forward-looking statements reflect the views of Nobel Biocare as of the date made with respect to future events and are subject to risks and uncertainties. All of these forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results or experience could differ materially from the forward-looking statements. Nobel Biocare disclaims any intention or obligation to update these forward-looking statements.
Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its key brands NobelActive™, Brånemark System®, NobelReplace™, NobelSpeedy™, Replace Select (dental implants), NobelProcera™ (individualized dental prosthetics), NobelGuide™ (complete patient rehabilitation program) and NobelSmile™ (patient education and awareness program). Nobel Biocare is a full solution provider for restorative esthetic dentistry, offering a wide range of innovative Crown & Bridge & Implant products, as well as training and education, patient information and clinically documented treatment concepts. Nobel Biocare has approximately 2,300 employees and recorded revenue of EUR 619.2 million in 2008. The Company is domiciled and headquartered in Zurich, Switzerland. Production takes place at six production sites located in Sweden, the US, Japan and Israel. Nobel Biocare has 37 direct sales organizations. The shares of the parent company Nobel Biocare Holding AG are listed on the SIX Swiss Exchange.